A more physiological model was also used in vitro, the LNCaP prostate cancer cells which overexpress the PSGR (Prostate Specific G protein-coupled Receptor), an endogenous and deorphanized OR considered as a tumor marker, and wich was described to inhibit the proliferation of these cells in vitro[12]. The gene discussed is OR51E2; the disease is prostate carcinoma.